Cataracts Infantile
Ophthalmology
7
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
6
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
6
Early DiscoveryClinical DevelopmentMarket
On Market (6)
Approved therapies currently available
U
BYQLOVIApproved
clobetasol propionate
Unknown Companyophthalmic2024
U
CLOBETASOL PROPIONATEApproved
clobetasol propionate
Unknown Companytopical2019
U
IMPEKLOApproved
clobetasol propionate
Unknown Companytopical2020
U
IMPOYZApproved
clobetasol propionate
Unknown Companytopical2017
U
OLUXApproved
clobetasol propionate
Unknown Companytopical2000
U
OLUX EApproved
clobetasol propionate
Unknown Companytopical2007
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
SalvatClobetasol Propionate
Clinical Trials (1)
Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population
Start: Dec 2022Est. completion: Dec 2025
Phase 3Recruiting
Related Jobs in Ophthalmology
Lead Data Manager
Genomics
Remote
8h ago
Cleanroom and Laboratory Technician
SAB BIO
8h ago
APAC Regulatory Affairs Manager
Johnson & Johnson
Singapore, Singapore
Yesterday
Clinical Operations Manager
Johnson & Johnson
Irvine, California, United States of America
Yesterday
$117K - $201K/yr
Site Delivery Leader MLL
Johnson & Johnson
Gent, East Flanders, Belgium
Yesterday
BM 喀什 PSR HY
Johnson & Johnson
Urumqi, Xinjiang, China
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials
1 companies competing in this space